Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Axogen Inc (AXGN)

Axogen Inc (AXGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes GlobeNewswire - Mon Jul 20, 3:05PM CDT

Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experience Cory Anderson promoted to Executive Vice President and General Manager,...

AXGN : 39.73 (+0.91%)
STIM : 1.8800 (-2.59%)
Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026 GlobeNewswire - Wed Jul 15, 6:00AM CDT

ALACHUA, Fla. and TAMPA, Fla., July 15, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 39.73 (+0.91%)
MarketBeat.com
AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam MarketBeat - Thu May 14, 10:06AM CDT

AxoGen (NASDAQ:AXGN) President and CEO Michael Dale said the company’s growth strategy remains centered on developing the market for peripheral nerve repair, while recent reimbursement wins are expected...

AXGN : 39.73 (+0.91%)
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues GlobeNewswire - Thu Apr 30, 3:43PM CDT

MALVERN, Pa., April 30, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today...

AXGN : 39.73 (+0.91%)
TELA : 0.7110 (-2.96%)
ANIK : 14.67 (-2.27%)
MDXG : 4.13 (-0.96%)
ELUT : 0.9325 (+0.05%)
BVS : 11.48 (-1.29%)
Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference GlobeNewswire - Thu Apr 30, 6:00AM CDT

ALACHUA, Fla. and TAMPA, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 39.73 (+0.91%)
AxoGen: Q1 Earnings Snapshot AP - Tue Apr 28, 6:11AM CDT

AxoGen: Q1 Earnings Snapshot

AXGN : 39.73 (+0.91%)
Axogen, Inc. Reports First Quarter 2026 Financial Results GlobeNewswire - Tue Apr 28, 6:00AM CDT

ALACHUA, Fla. and TAMPA, Fla., April 28, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 39.73 (+0.91%)
Axogen's First BLA-Approved Quarter Could Validate the Revenue Model That Investors Bet On Barchart - Mon Apr 27, 4:02PM CDT

Barchart Research What to Expect from AXGN Earnings AXGN Generated April 27, 2026 Current Price $39.39 EPS Estimate $$-0.28 Consensus Rating Strong Buy Average Move 16.78% Axogen's First BLA-Approved Quarter...

AXGN : 39.73 (+0.91%)
CVRx Announces Nomination of Michael Dale for Election to the Board of Directors GlobeNewswire - Mon Apr 20, 3:30PM CDT

MINNEAPOLIS, April 20, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients...

AXGN : 39.73 (+0.91%)
CVRX : 4.89 (-3.93%)
Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026 GlobeNewswire - Tue Apr 14, 6:00AM CDT

ALACHUA, Fla. and TAMPA, Fla., April 14, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral...

AXGN : 39.73 (+0.91%)

Barchart Exclusives

CapEx Fears Eclipse Alphabet’s Strong Q2, but GOOGL Stock Still Looks Attractive Barchart - Thu Jul 23, 6:30PM CDT
While GOOGL stock could remain volatile as investors digest elevated spending, Alphabet remains well positioned to benefit from the accelerating AI investment cycle. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.